Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    62,707.01
    -1,281.20 (-2.00%)
     

  • CMC Crypto 200

    1,315.65
    -80.88 (-5.79%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • Dow

    38,239.66
    +153.86 (+0.40%)
     

  • Nasdaq

    15,927.90
    +316.14 (+2.03%)
     

  • Gold

    2,349.60
    +7.10 (+0.30%)
     

  • Crude Oil

    83.66
    +0.09 (+0.11%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Stocks rise, breaking a three-day losing streak

US stocks rise, breaking a three-day losing streak; Gilead slumps on pressure over new drug

Associated Press

Trader James Riley, center, works on the floor of the New York Stock Exchange, Tuesday, April 8, 2014. Stocks were mixed in early trading on Tuesday after a three-day slump. Investors will start to focus on company earnings this week. (AP Photo/Richard Drew)

NEW YORK (AP) -- Stocks are closing higher as the market stabilizes after a three-day slump.

Technology stocks rose after taking a beating over the past week.

Investors will start to focus on company earnings this week. Bed Bath & Beyond reports after the market closes Wednesday and JPMorgan Chase releases its results on Friday.

The Standard & Poor's 500 index rose six points, or 0.4 percent, to close at 1,851 Tuesday.

The Dow Jones industrial average edged up 10 points, less than 0.1 percent, to 16,256.

The Nasdaq composite rose 33 points, or 0.8 percent, to 4,113.

Gilead Sciences fell 3 percent following reports that Express Scripts plans to ask its clients to join a coalition that would stop using Gilead's Sovaldi Hepatitis C treatment once a rival medicine is approved.